2004

Specific Immunotherapy For Epilepsy Via GluR3B Peptide Oral Vaccination Or Anti-GluR3B Peptide Antibodies Administration

Vivian I. Teichberg, PhD
Weizmann Institute of Science, Israel
 

In the last few years, immunotherapy has emerged as a possible treatment for diseases of the central nervous system, including epilepsy. Dr. Teichberg is investigating the scope and efficacy of vaccination against a particular AMPA receptor in epilepsy. This is an important preliminary look at the potential of vaccination in epilepsy as a means of achieving ‘no seizures-no side effects’.

Stay up-to-date with CURE news & epilepsy research discoveries.

Required field missing
Email address invalid